Monitor the preliminary prospectus supplement for offering size and pricing details. Expect near-term stock pressure due to dilution uncertainty; a smaller-than-expected offering could mitigate selling pressure.
Price Chart
Executive Summary
Aura Biosciences announced an underwritten public offering of common stock and pre-funded warrants, with a 30-day underwriter option for an additional 15%. The offering size and pricing are undisclosed, creating dilution uncertainty for existing shareholders.
Key Facts
- Offering includes common stock and pre-funded warrants; underwriters have 30-day option for 15% additional shares.
- Leerink Partners, TD Cowen, Evercore ISI, LifeSci Capital, and Citizens Capital Markets are managing the offering.
- Offering is under an existing effective shelf registration statement (S-3 filed March 2024).
- Proceeds intended for pipeline development of bel-sar (AU-011) for solid tumors.
Financial Impact
Undisclosed amount; dilution proportional to offering size, likely significant given $450M market cap
Risk Factors
- Dilution from offering may reduce EPS and ownership for current shareholders.
- No pricing or size disclosed creates uncertainty; stock may decline until terms are known.
- Clinical-stage biotech offerings often face adverse market reaction due to cash burn concerns.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3286509 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 5w ago | Institutional Cluster | $6.45 $6.56 | ▲ +1.71% | ▲ +2.27% | $6.30 (−2.33%) |
Aug 21, 2026 9w ago | EFFECT | $7.80 $6.36 | ▲ +18.46% | ▲ +17.94% | $6.30 (+19.23%) |
Aug 11, 2026 11w ago | 8-K | $8.04 $7.20 | ▲ +10.45% | ▲ +9.39% | $6.30 (+21.64%) |
Aug 11, 2026 11w ago | Press Release | $8.04 $7.20 | ▲ +10.45% | ▲ +9.39% | $6.30 (+21.64%) |
Jul 8, 2026 15w ago | 8-K | $7.25 $7.18 | ▼ −0.97% | ▼ −4.24% | $6.30 (−13.10%) |
May 19, 2026 23w ago | Press Release | $7.47 $6.34 | ▼ −15.13% | ▼ −15.87% | $6.30 (−15.66%) |
May 5, 2026 25w ago | 8-K | $8.29 $6.88 | ▲ +17.01% | ▲ +19.79% | $6.30 (+24.00%) |
May 5, 2026 25w ago | Press Release | $8.29 $6.88 | ▲ +17.01% | ▲ +19.79% | $6.30 (+24.00%) |
May 4, 2026 25w ago | 8-K | $8.90 $6.90 | ▼ −22.47% | ▼ −27.43% | $6.30 (−29.21%) |
May 4, 2026 25w ago | Press Release | $8.35 $7.19 | ▲ +13.89% | ▲ +19.54% | $6.30 (+24.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers